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SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure
..Acute-on-chronic liver failure patients (n = 88, mean age 47.3 ± 10.9 years) with refractory variceal bleeds received either Danis stent (Gr. A, n = 35) or continued with repeat endotherapy and vasoactive drug (Gr.B, n = 53). Control of initial bleeding was significantly more in the Danis stent group as compared to controls in both pre-match (89 vs. 37%; p < 0.001) and 0.007) . Further, bleed-related death was also significantly lower in Danis group as compared to controls in both p = 0.001) . In a multivariate competing risk Cox model, patients who underwent DE stenting had reduced mortality in both HR 0.36, and HR 0.21, New York: Oxford University Press, xxxvii, 869 p., . On pages 232-233, you will find a synoptic chart listing the key points of management of variceal bleeding. In the point where the techniques for temporary stabilisation of the patient with uncontrolled variceal bleeding are mentioned, there is also stated that: "...Some centres are now using DANIS stents..." The Sengstaken-Blakemore or Linton tube can only be used in settings where experienced staff is available, whereas the use of the Danis stent is easy for the staff and significantly safer for the patient.
Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
Spaander M. C. W., Baron T. H., Siersema P. D. ESGE recommends considering placement of a SEMS for the treatment of esophageal variceal bleeding refractory to medical, endoscopic, and/or radiological therapy, or as initial therapy for patients with massive bleeding (strong recommendation, moderate quality evidence).
